Abstract
We report "smart" nickel oxide nanoparticles (NOPs) as multimodal cancer therapy agent. Water-dispersible and light-sensitive NiO core was synthesized with folic acid (FA) connected bovine serum albumin (BSA) shell on entrapped doxorubicin (DOX). The entrapped drug from NOP-DOX@BSA-FA was released in a sustained way (64 hours, pH=5.5, dark conditions) while a robust release was found under red light exposure (in 1/2 hour under λmax = 655 nm, 50 mW/cm2, at pH=5.5). The cell viability, thiobarbituric acid reactive substances and diphenylisobenzofuran assays conducted under light and dark conditions revealed a high photodynamic therapy potential of our construct. Furthermore, we found that the combined effect of DOX and NOPs from NOP-DOX@BSA-FA resulted in cell death approximately eightfold high compared to free DOX. We propose that NOP-DOX@BSA-FA is a potential photodynamic therapy agent and a collective drug delivery system for the systemic administration of cancer chemotherapeutics resulting in combination therapy.
Author supplied keywords
Cite
CITATION STYLE
Bano, S., Nazir, S., Munir, S., Fahad Al-Ajmi, M., Afzal, M., & Mazhar, K. (2016). “Smart” nickel oxide based core-shell nanoparticles for combined chemo and photodynamic cancer therapy. International Journal of Nanomedicine, 11, 3159–3166. https://doi.org/10.2147/IJN.S106533
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.